
Regeneron Pharmaceuticals (REGN) Latest News & Updates
Explore latest Regeneron Pharmaceuticals (REGN) News and Updates
Stay updated on Regeneron Pharmaceuticals (REGN) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Regeneron Pharmaceuticals (REGN)
Order type
Buy in
Order amount
Est. shares
0 shares
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
GlobeNewsWire •

GlobeNewsWire •



Zacks Investment Research •

GlobeNewsWire •


GlobeNewsWire •

GlobeNewsWire •

InvestorPlace •

GlobeNewsWire •




Benzinga •

GlobeNewsWire •






Zacks Investment Research •



GlobeNewsWire •
